1. Anti‐NeuGcGM3 reactivity: a possible role of natural antibodies and B‐1 cells in tumor immunosurveillance
   Nely Rodriguez‐Zhurbenko et al, 2015, Annals of the New York Academy of Sciences CrossRef
2. Site-SpecificN-Glycosylation of Recombinant Pentameric and Hexameric Human IgM
   Edward S. X. Moh et al, 2016, Journal of the American Society for Mass Spectrometry CrossRef
3. Beyond the Role of CD55 as a Complement Component
   So Hee Dho et al, 2018, Immune Network CrossRef
4. The role of B-1 cells in cancer progression and anti-tumor immunity
   Nely Rodríguez-Zhurbenko et al, 2024, Frontiers in Immunology CrossRef
5. Considerations for the Design of Antibody-Based Therapeutics
   Dennis R. Goulet et al, 2020, Journal of Pharmaceutical Sciences CrossRef
6. CD55 in cancer: Complementing functions in a non-canonical manner
   Rashmi Bharti et al, 2022, Cancer Letters CrossRef
7. Impact of temperature and pH on recombinant human IgM quality attributes and productivity
   Julia Hennicke et al, 2019, New Biotechnology CrossRef
8. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
   Maya R. MacLean et al, 2024, International Journal of Molecular Sciences CrossRef
9. Glycan profile of CHO derived IgM purified by highly efficient single step affinity chromatography
   Julia Hennicke et al, 2017, Analytical Biochemistry CrossRef
10. The active form of Helicobacter pylori vacuolating cytotoxin induces decay‐accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa
    Kazuyo Kaneko et al, 2022, The Journal of Pathology CrossRef
11. Complement system's role in cancer and its therapeutic potential in ovarian cancer
    H. Bareke et al, 2018, Scandinavian Journal of Immunology CrossRef
12. Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer
    So Hee Dho et al, 2018, Scientific Reports CrossRef
13. CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma
    F Cimmino et al, 2016, Oncogenesis CrossRef
14. Structure, Function, and Therapeutic Use of IgM Antibodies
    Bruce A. Keyt et al, 2020, Antibodies CrossRef
15. A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
    Davide Busato et al, 2023, Journal of Translational Medicine CrossRef
16. Glycoarrays for diagnosis and therapy of the disorders of the female reproductive system
    N. V. Shilova et al, 2021, Russian Journal of Immunology CrossRef